XTL Biopharmaceutica (Israel) Price on May 1, 2024

XTLB Stock  ILS 6.10  0.10  1.67%   
If you're considering investing in XTL Stock, it is important to understand the factors that can impact its price. As of today, the current price of XTL Biopharmaceutica stands at 6.10, as last reported on the 13th of December 2024, with the highest price reaching 6.10 and the lowest price hitting 6.10 during the day. XTL Biopharmaceuticals shows Sharpe Ratio of -0.13, which attests that the company had a -0.13% return per unit of standard deviation over the last 3 months. XTL Biopharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XTL Biopharmaceutica's Risk Adjusted Performance of (0.08), mean deviation of 3.28, and Standard Deviation of 5.25 to validate the risk estimate we provide.
  
XTL Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.128

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsXTLB

Estimated Market Risk

 5.99
  actual daily
53
53% of assets are less volatile

Expected Return

 -0.77
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.13
  actual daily
0
Most of other assets perform better
Based on monthly moving average XTL Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XTL Biopharmaceutica by adding XTL Biopharmaceutica to a well-diversified portfolio.

Related Headline

XTL Biopharmaceutica Headline on 1st of May 2024

Filed transaction by XTL Biopharmaceuticals Ltd 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3

XTL Biopharmaceutica Valuation on May 1, 2024

It is possible to determine the worth of XTL Biopharmaceutica on a given historical date. On May 1, 2024 XTL was worth 9.2 at the beginning of the trading date compared to the closed value of 9.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of XTL Biopharmaceutica stock. Still, in general, we apply an absolute valuation method to find XTL Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of XTL Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against XTL Biopharmaceutica's related companies.
 Open High Low Close Volume
  9.20    9.70    8.80    9.30    3,164,550  
05/01/2024
  9.20    10.10    9.20    9.70    4,376,023  
  9.60    9.90    9.10    9.50    3,044,036  
Backtest XTL Biopharmaceutica  |  XTL Biopharmaceutica History  |  XTL Biopharmaceutica Valuation   PreviousNext  
Open Value
9.2
9.7
Closing Value
27.17
Upside

XTL Biopharmaceutica Trading Date Momentum on May 1, 2024

On May 02 2024 XTL Biopharmaceuticals was traded for  9.50  at the closing time. The highest price during the trading period was 9.90  and the lowest recorded bid was listed for  9.10 . The volume for the day was 3 M. This history from May 2, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 2.06% . The trading price change to the current price is 3.09% .

XTL Biopharmaceuticals Fundamentals Correlations and Trends

By evaluating XTL Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among XTL Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. XTL financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About XTL Biopharmaceutica Stock history

XTL Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XTL is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XTL Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XTL Biopharmaceutica stock prices may prove useful in developing a viable investing in XTL Biopharmaceutica
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel. XTL BIOPHARMACEUTI is traded on Tel Aviv Stock Exchange in Israel.

XTL Biopharmaceutica Stock Technical Analysis

XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of XTL Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of XTL Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

XTL Biopharmaceutica Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

XTL Biopharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

XTL Biopharmaceutica December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying XTL Biopharmaceutica stock market strength indicators, traders can identify XTL Biopharmaceuticals entry and exit signals to maximize returns

XTL Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for XTL Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of XTL Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XTL to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for XTL Stock analysis

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets